Independent Advisor Alliance’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-5,280
Closed -$381K – 691
2022
Q1
$381K Sell
5,280
-410
-7% -$29.5K 0.02% 463
2021
Q4
$522K Buy
5,690
+197
+4% +$23.5K 0.03% 389
2021
Q3
$697K Sell
5,493
-878
-14% -$128K 0.04% 317
2021
Q2
$1.06M Sell
6,371
-3,738
-37% -$606K 0.06% 272
2021
Q1
$1.84M Buy
10,109
+55
+0.5% +$12.8K 0.11% 161
2020
Q4
$2.01M Sell
10,054
-19,876
-66% -$4.04M 0.14% 134
2020
Q3
$6.56M Buy
29,930
+26,693
+825% +$5.65M 0.5% 54
2020
Q2
$618K Buy
3,237
+1,402
+76% +$246K 0.07% 226
2020
Q1
$284K Buy
+1,835
New +$213K 0.04% 290

Other funds holding TDOC

Independent Advisor Alliance's TDOC Position: Q2 2022 in Review

Independent Advisor Alliance sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 5,280 shares — an estimated $381K sold.

Independent Advisor Alliance first reported a position in TDOC in Q1 2020 and held it in 9 quarters. The position peaked at $6.56M in Q3 2020. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Independent Advisor Alliance reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Independent Advisor Alliance sold 5,280 Teladoc Health shares in Q2 2022, an estimated $381K.
  • Independent Advisor Alliance first reported a position in Teladoc Health in Q1 2020 and held it in 9 quarters.
  • Independent Advisor Alliance's Teladoc Health position peaked at $6.56M in Q3 2020.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Independent Advisor Alliance's 13F filing for Q2 2022, filed 4 Aug 2022.